Latest drug discovery Stories
AMRI to purchase Glasgow, UK and West Lafayette, Indiana, U.S.A. sites GREENWICH, Conn., Jan. 9, 2015 /PRNewswire/ -- Dr.
Selexis SA announced today the first therapeutic biologic generated with the Selexis SUREtechnology Platform™ has been approved for market. Geneva, Switzerland
BETHESDA, Md., Jan. 8, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a U.S.
LONDON and BOSTON, January 8, 2015 /PRNewswire/ -- Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is pleased to
Collaboration Aims to Generate New Therapeutic Approaches for Chronic Diseases SAN FRANCISCO, Jan.
- Vtesse to collaborate with National Institutes of Health on development of VTS-270 for Niemann-Pick Disease Type C and other novel drugs for life-threatening rare diseases GAITHERSBURG,
BISHOPS STORTFORD, England, January 6, 2015 /PRNewswire/ -- Dotmatics team strengthened to support continued rapid growth in business Dotmatics [http://www.dotmatics.com
ReportsnReports.com adds “Vertigo Global Clinical Trials Review, H2, 2014” to its store.
ReportsnReports.com adds “Chronic Bronchitis Global Clinical Trials Review H2 2014” to its store.
- totally perplexed and mixed up.